Risk adjustment in Germany
        Dr. Dirk Göpffarth, German Federal Insurance Agency




                      Risk Adjustment Conference 2011
                            London, 29 June 2011

6. Juli 2011     Bundesversicherungsamt · Friedrich-Ebert-Allee 38 · 53113 Bonn
                                                                              1
I.
Health Care System in Germany




                                2
Statutory Health Insurance in Germany:
                 Coverage

• 70 million covered (out of a population of 80
  million)
• coverage mandatory for employees up to an
  income threshold of € 4.125 per month
• coverage voluntary for high-income
  employees, self-employed and civil servants
  if they were covered by the SHI beforehand
• otherwise these groups can opt for private
  health insurance (risk assessment)
• special rules for farmers
                                                  3
Statutory Health Insurance in Germany:
                    Benefits

•   95 % of benefits mandated
•   broad coverage of all “medically necessary”
    benefits, including office-based physicians’
    treatment (including specialists), dental
    care, prescription drugs, hospital treatment,
    sickness payments, (within limits)
    physiotherapy etc.
•   co-payments: generally 10 % (minimum 5 €,
    maximum 10 €), for office-based physicians
    10 Euro every quarter
•   provision otherwise free at point of service
                                               4
Statutory Health Insurance in Germany:
                  Carriers

• currently approx. 147 sickness funds
  – 1991: more than 1.200 sickness funds
  – 2008: 206 sickness funds
• Organisation: incorporated bodies of public
  law with self-administration
• Different “kinds” of funds: local funds,
  company funds, guild funds, substitute funds,
  special systems for miners, seamen, farmers
• since 1996: free choice of sickness fund
• since 2007: merger of funds of different
  “kinds” possible
                                              5
Role of Central Health Fund
              in Financing Health Care

         Tax Subsidies       Contributions
             € 15.5 bn           € 159.0 bn



                    Central Health
                        Fund                   Additional Premia
                                                      € 0.7 bn
                             Risk-adjusted
                             payments


                  Sickness Funds


Physicians      Hospitals        Drugs        Other
 € 28.5 bn       € 57.4 bn      € 30.0 bn     € 45.2 bn

                                                                 2010 figures
                                                                      6
Some Facts on the
  German Federal Insurance Agency (BVA)

• Supervisory authority for ‘federal’ social
  insurance institutions (sickness funds,
  pension funds, employers’ liability insurance,
  long term care insurance)
• Audit office for ‘federal’ sickness funds
• ‘Administrative tasks: Central Health Fund,
  Risk adjustment, licensing Disease-
  Management-Programs
• 540 staff, head office in Bonn


                                               7
II.
Risk Adjustment in Germany




                             8
Evolvement of Risk Adjustment in Germany


      Age             Age             Age

    Gender          Gender          Gender

  Disability to   Disability to   Disability to
     work            work            work

                  Enrolement       Morbidity
                   in Disease
                  Management

                   Risk Pool


      1994            2003            2009



                                                  9
Reasons for Introducing Risk Adjustment
                  in 1994

• Before 1996, most insured were allocated to
  a fund, only white-collar workers could opt for
  substitute fund
• Expenditure for pensioners was pooled
⇒Pooling led to low incentives for cost control
⇒Restriction of choice became politically
  untenable, large differences in contribution
  rates
⇒Legal challenges

                                               10
Reasons for Reforming Risk Adjustment
                 in 2001

• Functionality of competition
   Sickness funds tried to attract young and healthy
     switchers
• Incentives for providing care for chronically ill
⇒Short term: Disease Management Programs
  and Risk Pool
⇒Long term: Introduction of morbidity-based
  risk adjustment by 2007
   Later political compromise: Postponement to 2009
     and restriction to 80 disease states

                                                       11
Overview over the risk adjustment system
             implemented in Germany




                                                                       approx. 4.000 diagnoses




                                                                                                                  classification model
                                                                                                                                             Risk adjustors
             plausibility checks




                                                    • definition of                                eligibility




                                                                         80 disease states
 Inpatient
                                                      diseases                                      criteria                             • 40 Age-Sex-Groups
                                   disease filter




    and
outpatient                                          • severity                                     validation                            • 6 groups for disability-
diagnoses                                                                                          of                                      to-work-status
                                                    • chronic
ICD-10-GM                                                                                          diagnoses
                                                    • cost-intensive                               eg. with                              • 128 hierarchical
                                                                                                   drug data                               morbidity groups
                                                    • cost threshold




                                                                                                 Pharmaceutical
                                                                                                     agents
                                                                                                   ATC-Codes
                                                                                                                                                            12
Eligibility criteria:
  Not every diagnosis leads to a payment

• All outpatient diagnoses have to be validated
  by a second diagnoses of the same disease
  in a different quarter of the year
• DxGroups implying a necessary in-patient
  treatment (eg. acute myocardial infarct)
  cannot be triggered by outpatient diagnosis
• DxGroups with necessary drug treatment (eg.
  Diabetes mellitus Typ 1) have to be validated
  by use of corresponding pharmaceutical
  agents

                                             13
Calculation of monthly payments


              Age-Gender-              Disability-to-         Hierarchical Morbidity Groups
                Groups                 work-Groups
                                                                        25 Hierarchies
              Female
              0y        166    €
              1-5 y    -131    €                                  Diabetes               Ophthalmic
                 ...     ...           Female
 Lump         40-44y   -120    €       <45 y     273 €
                                                              HMG015    HMG020            HMG222
                                                               170 €     159 €             62 €
  sum            ...     ...
                                       45-54 y   171 €
              90-94y    -35    €
payment   +                        +   55-64 y    88 €    +   HMG016               ...    HMG223
              95y+      -72    €
                                       Male                    161 €                       54 €
              Male
 203 €        0y        223    €       <45 y     223 €
                                       45-54 y   151 €        HMG017                      HMG224
              1-5 y    -119    €                               103 €                       xxx €
                 ...     ...           55-64 y   105 €
              40-44y   -140    €                              HMG019
                 ...     ...                                   48 €
              90-94y    -39    €
              95y+      -54    €




 100%           100%                        2%                               66%
                                            eligibility

                                                                                                 14
Annual revision of the model


•Recalibration   •High cost groups / splits by pharmaceuticals
of weights
•Revision of         HIV/AIDS          Metabolic Diseases   Haemophilia
                 with antiretroviral                        with full factor
hierarchies           therapy
                                         with ERT/SRT
                                                            replacement
                                            25.124 €
                      1.481 €                                  18.935 €
•Revision of
eligibility         HIV/AIDS                                Haemophilia
                                       Metabolic Diseases
criteria         w/o antiretroviral                         w/o full factor
                                        with Somatropin
                     therapy                                 replacement
                                             1.504 €
                      233 €                                 men: 1.333 €
•Revision of                                                women: 226 €
modalities
                                       Metabolic Diseases
                                        without ERT/SRT
•Consultation                                456 €
process

                                                                               15
III.
First Experiences with the new formula




                                         16
Individual Level Measures


• Coefficient of determination (R2)
                                     R2      MAPE
     New formula (2009)             19,6 %    1.953
     Prior formula with risk pool   52,3 %    2.019
     Prior formula w/o risk pool     5,8 %    2.226

• R2 for 2011 model about 25 %




                                                      17
Predictive Ratio (Predicted payments to observed payments)
                                                                                Group Level Measures

                                                             180%


                                                             160%
                                                                                                      New Formula (2009)
                                                             140%                                     Prior Formula with Risk Pool
                                                                                                      Prior Formula without Risk Pool
                                                             120%


                                                             100%


                                                             80%


                                                             60%


                                                             40%


                                                             20%


                                                              0%
                                                                    0: no HMG      1: one HMG   2: two HMG        3: three HMG          4: four or more


                                                                                                                                                          18
Sickness Fund Level Measures
                                       (New Formula)
                   130%


                   125%                                            less than 30.000 insured
                                                                   30.000 through 1.000.000 insured
                   120%
                                                                   more than 1.000.000 insured
                   115%
Predictive Ratio




                   110%


                   105%


                   100%


                   95%
                                                                                  y = -0,0461x + 1,048
                   90%
                                                                                           R2 = 14,9 %


                   85%


                   80%
                          0,6    0,7   0,8   0,9    1,0      1,1          1,2        1,3          1,4    1,5
                                                   Case Mix Index

                                                                                                         19
Sickness Fund Level Measures
                                        (Old Formula)
                   130%


                   125%                                            less than 30.000 insured
                                                                   30.000 through 1.000.000 insured
                   120%
                                                                   more than 1.000.000 insured
                   115%
Predictive Ratio




                   110%


                   105%


                   100%


                   95%


                   90%
                                                                                     y = -0,1142x + 1,1184
                   85%                                                                    R2 = 26,6 %


                   80%
                          0,6    0,7   0,8   0,9    1,0      1,1          1,2        1,3         1,4     1,5
                                                   Case Mix Index

                                                                                                             20
Problems with the New Risk Adjustment
                   Formula

• People without diagnosis data (living abroad
  or choosing cost reimbursement)
    – Legislation for “carve outs”
•   Payments for high cost cases
•   Predictability of payments
•   Upcoding / Gaming
•   “Big bang” introduction together with Central
    Health Fund, Additional Premia and
    Insolvency Rules
    – First insolvency of a fund in July 2011
                                                    21
III.
Prospects of Risk Adjustment in Germany




                                      22
Prospects for Risk Adjustment in Germany


• Coalition Agreement: Reduce morbidity-
  based risk adjustment, but so far no
  legislation
• Continuing Improvement of the model and of
  the data basis
• Discussion of introducing regional factors
• But no discussion of extending the scope of
  the model (80 disease states) or bringing in
  new adjustors (procedures or performance
  measures)
                                             23
Thank you for your attention




                               24

Dirk Gopffarth: Risk adjustment in Germany

  • 1.
    Risk adjustment inGermany Dr. Dirk Göpffarth, German Federal Insurance Agency Risk Adjustment Conference 2011 London, 29 June 2011 6. Juli 2011 Bundesversicherungsamt · Friedrich-Ebert-Allee 38 · 53113 Bonn 1
  • 2.
  • 3.
    Statutory Health Insurancein Germany: Coverage • 70 million covered (out of a population of 80 million) • coverage mandatory for employees up to an income threshold of € 4.125 per month • coverage voluntary for high-income employees, self-employed and civil servants if they were covered by the SHI beforehand • otherwise these groups can opt for private health insurance (risk assessment) • special rules for farmers 3
  • 4.
    Statutory Health Insurancein Germany: Benefits • 95 % of benefits mandated • broad coverage of all “medically necessary” benefits, including office-based physicians’ treatment (including specialists), dental care, prescription drugs, hospital treatment, sickness payments, (within limits) physiotherapy etc. • co-payments: generally 10 % (minimum 5 €, maximum 10 €), for office-based physicians 10 Euro every quarter • provision otherwise free at point of service 4
  • 5.
    Statutory Health Insurancein Germany: Carriers • currently approx. 147 sickness funds – 1991: more than 1.200 sickness funds – 2008: 206 sickness funds • Organisation: incorporated bodies of public law with self-administration • Different “kinds” of funds: local funds, company funds, guild funds, substitute funds, special systems for miners, seamen, farmers • since 1996: free choice of sickness fund • since 2007: merger of funds of different “kinds” possible 5
  • 6.
    Role of CentralHealth Fund in Financing Health Care Tax Subsidies Contributions € 15.5 bn € 159.0 bn Central Health Fund Additional Premia € 0.7 bn Risk-adjusted payments Sickness Funds Physicians Hospitals Drugs Other € 28.5 bn € 57.4 bn € 30.0 bn € 45.2 bn 2010 figures 6
  • 7.
    Some Facts onthe German Federal Insurance Agency (BVA) • Supervisory authority for ‘federal’ social insurance institutions (sickness funds, pension funds, employers’ liability insurance, long term care insurance) • Audit office for ‘federal’ sickness funds • ‘Administrative tasks: Central Health Fund, Risk adjustment, licensing Disease- Management-Programs • 540 staff, head office in Bonn 7
  • 8.
  • 9.
    Evolvement of RiskAdjustment in Germany Age Age Age Gender Gender Gender Disability to Disability to Disability to work work work Enrolement Morbidity in Disease Management Risk Pool 1994 2003 2009 9
  • 10.
    Reasons for IntroducingRisk Adjustment in 1994 • Before 1996, most insured were allocated to a fund, only white-collar workers could opt for substitute fund • Expenditure for pensioners was pooled ⇒Pooling led to low incentives for cost control ⇒Restriction of choice became politically untenable, large differences in contribution rates ⇒Legal challenges 10
  • 11.
    Reasons for ReformingRisk Adjustment in 2001 • Functionality of competition Sickness funds tried to attract young and healthy switchers • Incentives for providing care for chronically ill ⇒Short term: Disease Management Programs and Risk Pool ⇒Long term: Introduction of morbidity-based risk adjustment by 2007 Later political compromise: Postponement to 2009 and restriction to 80 disease states 11
  • 12.
    Overview over therisk adjustment system implemented in Germany approx. 4.000 diagnoses classification model Risk adjustors plausibility checks • definition of eligibility 80 disease states Inpatient diseases criteria • 40 Age-Sex-Groups disease filter and outpatient • severity validation • 6 groups for disability- diagnoses of to-work-status • chronic ICD-10-GM diagnoses • cost-intensive eg. with • 128 hierarchical drug data morbidity groups • cost threshold Pharmaceutical agents ATC-Codes 12
  • 13.
    Eligibility criteria: Not every diagnosis leads to a payment • All outpatient diagnoses have to be validated by a second diagnoses of the same disease in a different quarter of the year • DxGroups implying a necessary in-patient treatment (eg. acute myocardial infarct) cannot be triggered by outpatient diagnosis • DxGroups with necessary drug treatment (eg. Diabetes mellitus Typ 1) have to be validated by use of corresponding pharmaceutical agents 13
  • 14.
    Calculation of monthlypayments Age-Gender- Disability-to- Hierarchical Morbidity Groups Groups work-Groups 25 Hierarchies Female 0y 166 € 1-5 y -131 € Diabetes Ophthalmic ... ... Female Lump 40-44y -120 € <45 y 273 € HMG015 HMG020 HMG222 170 € 159 € 62 € sum ... ... 45-54 y 171 € 90-94y -35 € payment + + 55-64 y 88 € + HMG016 ... HMG223 95y+ -72 € Male 161 € 54 € Male 203 € 0y 223 € <45 y 223 € 45-54 y 151 € HMG017 HMG224 1-5 y -119 € 103 € xxx € ... ... 55-64 y 105 € 40-44y -140 € HMG019 ... ... 48 € 90-94y -39 € 95y+ -54 € 100% 100% 2% 66% eligibility 14
  • 15.
    Annual revision ofthe model •Recalibration •High cost groups / splits by pharmaceuticals of weights •Revision of HIV/AIDS Metabolic Diseases Haemophilia with antiretroviral with full factor hierarchies therapy with ERT/SRT replacement 25.124 € 1.481 € 18.935 € •Revision of eligibility HIV/AIDS Haemophilia Metabolic Diseases criteria w/o antiretroviral w/o full factor with Somatropin therapy replacement 1.504 € 233 € men: 1.333 € •Revision of women: 226 € modalities Metabolic Diseases without ERT/SRT •Consultation 456 € process 15
  • 16.
    III. First Experiences withthe new formula 16
  • 17.
    Individual Level Measures •Coefficient of determination (R2) R2 MAPE New formula (2009) 19,6 % 1.953 Prior formula with risk pool 52,3 % 2.019 Prior formula w/o risk pool 5,8 % 2.226 • R2 for 2011 model about 25 % 17
  • 18.
    Predictive Ratio (Predictedpayments to observed payments) Group Level Measures 180% 160% New Formula (2009) 140% Prior Formula with Risk Pool Prior Formula without Risk Pool 120% 100% 80% 60% 40% 20% 0% 0: no HMG 1: one HMG 2: two HMG 3: three HMG 4: four or more 18
  • 19.
    Sickness Fund LevelMeasures (New Formula) 130% 125% less than 30.000 insured 30.000 through 1.000.000 insured 120% more than 1.000.000 insured 115% Predictive Ratio 110% 105% 100% 95% y = -0,0461x + 1,048 90% R2 = 14,9 % 85% 80% 0,6 0,7 0,8 0,9 1,0 1,1 1,2 1,3 1,4 1,5 Case Mix Index 19
  • 20.
    Sickness Fund LevelMeasures (Old Formula) 130% 125% less than 30.000 insured 30.000 through 1.000.000 insured 120% more than 1.000.000 insured 115% Predictive Ratio 110% 105% 100% 95% 90% y = -0,1142x + 1,1184 85% R2 = 26,6 % 80% 0,6 0,7 0,8 0,9 1,0 1,1 1,2 1,3 1,4 1,5 Case Mix Index 20
  • 21.
    Problems with theNew Risk Adjustment Formula • People without diagnosis data (living abroad or choosing cost reimbursement) – Legislation for “carve outs” • Payments for high cost cases • Predictability of payments • Upcoding / Gaming • “Big bang” introduction together with Central Health Fund, Additional Premia and Insolvency Rules – First insolvency of a fund in July 2011 21
  • 22.
    III. Prospects of RiskAdjustment in Germany 22
  • 23.
    Prospects for RiskAdjustment in Germany • Coalition Agreement: Reduce morbidity- based risk adjustment, but so far no legislation • Continuing Improvement of the model and of the data basis • Discussion of introducing regional factors • But no discussion of extending the scope of the model (80 disease states) or bringing in new adjustors (procedures or performance measures) 23
  • 24.
    Thank you foryour attention 24